| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US5690960 | ASTRAZENECA | Pharmaceutical formulation of omeprazole |
Nov, 2014
(9 years ago) | |
| US5753265 | ASTRAZENECA | Multiple unit pharmaceutical preparation |
Jun, 2015
(8 years ago) | |
| US5817338 | ASTRAZENECA | Multiple unit tableted dosage form of omeprazole |
Oct, 2015
(8 years ago) | |
| US5900424 | ASTRAZENECA | Omeprazole magnesium salt form |
May, 2016
(8 years ago) | |
| US6428810 | ASTRAZENECA | Pharmaceutical formulation comprising omeprazole |
Nov, 2019
(4 years ago) | |
| US6403616 | ASTRAZENECA | Chemical process and pharmaceutical formulation |
Nov, 2019
(4 years ago) | |
Prilosec Otc is owned by Astrazeneca.
Prilosec Otc contains Omeprazole Magnesium.
Prilosec Otc has a total of 6 drug patents out of which 6 drug patents have expired.
Expired drug patents of Prilosec Otc are:
- US5690960
- US5753265
- US5817338
- US5900424
- US6428810
- US6403616
Prilosec Otc was authorised for market use on 20 June, 2003.
Prilosec Otc is available in tablet, delayed release;oral dosage forms.
The generics of Prilosec Otc are possible to be released after 15 November, 2019.
Drugs and Companies using OMEPRAZOLE MAGNESIUM ingredient
Market Authorisation Date: 20 June, 2003
Treatment: NA
Dosage: TABLET, DELAYED RELEASE;ORAL
How can I launch a generic of PRILOSEC OTC before it's drug patent expiration?
More Information on Dosage
PRILOSEC OTC family patents
